Alliance for Multispecialty Research Kansas City

Clinical research site in Kansas City, Missouri

Part of Alliance for Multispecialty Research

As of July 2026, 2 paid clinical trials are recruiting at Alliance for Multispecialty Research Kansas City in Kansas City, Missouri. Active studies at this site cover conditions such as Atherosclerotic Cardiovascular Disease, Overweight and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Alliance for Multispecialty Research Kansas City (2)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for Atherosclerotic Cardiovascular Disease

138 locations incl. Daphne

Sponsor: Amgen

Sex: All·Age: 45 - 99

Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

for Overweight or Obesity and Elevated Liver Fat

23 locations incl. Chandler

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07441252·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Explore more

Paid clinical trials in Kansas City, MO · Missouri clinical trials

Alliance for Multispecialty Research Kansas City

Recruiting clinical trials at Alliance for Multispecialty Research Kansas City (2)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

More research sites in Kansas City

Explore more